ClinicalTrials.gov
public full text
Public Domain
Treatment of PED With AMT and Autologous Serum
Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries#448198
- TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)#1085518
- EndoArt® Implantation in Subjects With Chronic Corneal Edema - US Study#892756
- Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection#1101062
- Early Manifest Glaucoma Trial (EMGT)#435791
Record · ID 868226
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive